Thomas Jennings

Associate Professor

UAMS

Last publication 2024 Last refreshed 2026-05-16

faculty

Dermatology, College of Medicine

9 h-index 23 pubs 554 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Dr. Thomas Jennings is an Associate Professor in the Department of Dermatology at the University of Arkansas for Medical Sciences, where he directs dermatologic surgery at the Winthrop P. Rockefeller Cancer Institute. His clinical practice focuses on Mohs micrographic surgery, reconstruction of complex surgical wounds, treatment of high-risk cutaneous cancers, and transplant dermatology. Dr. Jennings completed a fellowship in procedural dermatology and Mohs micrographic surgery at the University of Alabama Birmingham Medical Center.

His research interests include the application and outcomes of surgical techniques, as evidenced by his publications on Mohs micrographic surgery for melanoma and the use of fish skin xenografts. He has also contributed to the literature through systematic reviews and meta-analyses, examining perioperative outcomes in surgical procedures, including those performed by trainees. Dr. Jennings' work also touches upon medical education, with publications addressing resident confidence in hospital consults.

Research Overview

Using the vast resources of the only academic medical center in the state of Arkansas, Dr. Thomas Jennings provides personalized medical care to each of his patients. As director of dermatologic surgery at the Winthrop P. Rockefeller Cancer Institute, his services include:Mohs micrographic surgeryAesthetic reconstruction of complexsurgical woundsHigh risk cutaneous cancer treatment áTransplant dermatologyDr. Jennings completed a fellowship in procedural dermatology and Mohs micrographic surgery at the University of Alabama Birmingham Medical Center, where he completed over 1000 cases.

Metrics

h-index: 9
Publications: 23
Citations: 554

Selected Publications

Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study (2024)

3 citations DOI OpenAlex
Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature (2024)

2 citations DOI OpenAlex
43582 Use and Outcomes of Fish Skin Xenografts in Mohs and Other Dermatologic Surgeries (2023)

DOI OpenAlex
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma for Future Clinical Trials: A Modified Delphi Study (2023)

DOI OpenAlex
28644 Inpatient training modules increase dermatology resident confidence for hospital consults (2021)

DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

HCV NS3: Biological, Biochemical and Structural Analysis NIH Co-Investigator
HCV NS3 and NS5A: Biochemical Mechanisms and Biological Functions NIH Co-Investigator
No FP attached Castle Biosciences, Inc. Principal Investigator